Nan Fung Group Holdings’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-154,522
| Closed | -$1.78M | – | 26 |
|
|
2025
Q1 | $1.78M | Hold |
154,522
| – | – | 1.45% | 22 |
|
|
2024
Q4 | $1.31M | Hold |
154,522
| – | – | 1.12% | 23 |
|
|
2024
Q3 | $1.79M | Sell |
154,522
-64,755
| -30% | -$750K | 1.54% | 21 |
|
|
2024
Q2 | $2.58M | Hold |
219,277
| – | – | 2.76% | 13 |
|
|
2024
Q1 | $2.6M | Sell |
219,277
-85,000
| -28% | -$1.01M | 2.41% | 12 |
|
|
2023
Q4 | $3.73M | Buy |
304,277
+69,704
| +30% | +$854K | 2.32% | 10 |
|
|
2023
Q3 | $2.26M | Buy |
234,573
+29,853
| +15% | +$287K | 1.83% | 11 |
|
|
2023
Q2 | $1.84M | Buy |
204,720
+126,000
| +160% | +$1.13M | 1.18% | 17 |
|
|
2023
Q1 | $619K | Hold |
78,720
| – | – | 0.42% | 29 |
|
|
2022
Q4 | $532K | Hold |
78,720
| – | – | 0.37% | 27 |
|
|
2022
Q3 | $1.14M | Hold |
78,720
| – | – | 0.73% | 18 |
|
|
2022
Q2 | $775K | Hold |
78,720
| – | – | 0.53% | 22 |
|
|
2022
Q1 | $1.16M | Hold |
78,720
| – | – | 0.55% | 24 |
|
|
2021
Q4 | $1.04M | Hold |
78,720
| – | – | 0.31% | 27 |
|
|
2021
Q3 | $1.37M | Hold |
78,720
| – | – | 0.44% | 19 |
|
|
2021
Q2 | $1.89M | Buy |
+78,720
| New | +$1.89M | 0.59% | 17 |
|